Literature DB >> 1420749

A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.

N Washington1, J L Greaves, S Y Iftikhar.   

Abstract

This study was designed to compare the effectiveness of single doses of either Liquid Gaviscon or Algicon Suspension in the suppression of food and acid reflux into the oesophagus after a test meal in volunteers. After the pH electrode and gamma detector were positioned 5 cm above the cardia, the volunteers received a refluxogenic radiolabelled meal. The subjects then remained untreated, or thirty minutes later they were given a dose of unlabelled Algicon Suspension, or Liquid Gaviscon and a recording was made for a minimum of 3 hours. Allocation to the treatment group was randomized with the cross-overs performed 1 week apart. Liquid Gaviscon suppressed gastro-oesophageal reflux of both food and acid whereas only an insignificant reduction in reflux was seen after Algicon Suspension. The oesophageal pH remained below 4 for 3.21 +/- 0.92% (S.E.M.) of the recording period in the control study, 0.88 +/- 0.33 after Gaviscon and 2.91 +/- 0.68 after Algicon. The reflux of food was reduced from 17,070 x 10(3) +/- 4713 x 10(3) counts in the control study to 224 x 10(3) +/- 93 x 10(3) counts after the Gaviscon and 16,080 x 10(3) +/- 7131 x 10(3) counts after Algicon. The suppression of reflux by Liquid Gaviscon was significantly better than that produced by Algicon Suspension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420749     DOI: 10.1111/j.1365-2036.1992.tb00572.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease.

Authors:  I-Rue Lai; Ming-Shiang Wu; Jaw-Town Lin
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

2.  Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconstant.

Authors:  E Colas-Atger; B Bonaz; E Papillon; N Gueddah; A Rolachon; R Bost; J Fournet
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 3.  Radiopharmaceuticals and the gastrointestinal tract.

Authors:  M Frier; A C Perkins
Journal:  Eur J Nucl Med       Date:  1994-11

4.  An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.

Authors:  M A Kwiatek; S Roman; A Fareeduddin; J E Pandolfino; P J Kahrilas
Journal:  Aliment Pharmacol Ther       Date:  2011-05-03       Impact factor: 8.171

5.  Alginate controls heartburn in patients with erosive and nonerosive reflux disease.

Authors:  Edoardo Savarino; Nicola de Bortoli; Patrizia Zentilin; Irene Martinucci; Luca Bruzzone; Manuele Furnari; Santino Marchi; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

6.  Non-invasive detection of gastro-oesophageal reflux using an ambulatory system.

Authors:  N Washington; H A Moss; C Washington; J L Greaves; R J Steele; C G Wilson
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.